- Home
- CBAT vs MNOV Comparison
CBAT vs MNOV Comparison
Compare CBAT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- MNOV
- Stock Information
- Founded
- CBAT 1999
- MNOV 2000
- Country
- CBAT China
- MNOV United States
- Employees
- CBAT N/A
- MNOV N/A
- Industry
- CBAT Industrial Machinery/Components
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- CBAT Miscellaneous
- MNOV Health Care
- Exchange
- CBAT Nasdaq
- MNOV Nasdaq
- Market Cap
- CBAT 97.1M
- MNOV 87.3M
- IPO Year
- CBAT N/A
- MNOV 2005
- Fundamental
- Price
- CBAT $0.94
- MNOV $1.83
- Analyst Decision
- CBAT
- MNOV
- Analyst Count
- CBAT 0
- MNOV 0
- Target Price
- CBAT N/A
- MNOV N/A
- AVG Volume (30 Days)
- CBAT 320.3K
- MNOV 136.9K
- Earning Date
- CBAT 11-12-2024
- MNOV 11-13-2024
- Dividend Yield
- CBAT N/A
- MNOV N/A
- EPS Growth
- CBAT N/A
- MNOV N/A
- EPS
- CBAT 0.12
- MNOV N/A
- Revenue
- CBAT $207,423,403.00
- MNOV N/A
- Revenue This Year
- CBAT $10.76
- MNOV N/A
- Revenue Next Year
- CBAT $15.32
- MNOV N/A
- P/E Ratio
- CBAT $7.77
- MNOV N/A
- Revenue Growth
- CBAT 2.32
- MNOV N/A
- 52 Week Low
- CBAT $0.79
- MNOV $1.12
- 52 Week High
- CBAT $2.08
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- CBAT 36.09
- MNOV 52.22
- Support Level
- CBAT $0.92
- MNOV $1.49
- Resistance Level
- CBAT $1.15
- MNOV $2.55
- Average True Range (ATR)
- CBAT 0.06
- MNOV 0.18
- MACD
- CBAT -0.02
- MNOV 0.03
- Stochastic Oscillator
- CBAT 9.57
- MNOV 36.84
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization and distribution of a variety of standard and customized lithium-ion high-power rechargeable batteries. The company operates in two operating segments: CBAK's segment mainly includes the manufacture, commercialization and distribution of a wide variety of standard and customized lithium ion rechargeable batteries for use in a wide array of applications. Hitrans' segment mainly includes the development and manufacturing of NCM precursor and cathode materials. Geographically, it generates a majority of its revenue from Mainland China and also has an operation in Europe, the United States, Korea, and Other Countries.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.